Kohlberg Kravis Roberts & Co
ZMH set to acquire EU approval for $13B Biomet deal | The week in medtech M&A
Philips mulls 2016 IPO for lighting biz as bidding war heats up
ZMH to float $7.7B debt to acquire Biomet | The week in medtech M&A
Private equity shops battle for Philips’ legacy lighting biz
Biomet puts itself back on public market | Medtech Wall Street news for the week of Mar. 10, 2014
Biomet announces IPO plans
March 7, 2014 by Brad Perriello
Biomet is planning to put itself back on the public market after a 7-year run under private equity ownership, the orthopedics giant said today.
Biomet announces IPO plans
Biomet is planning to put itself back on the public market after a 7-year run under private equity ownership, the orthopedics giant said today.
A group of private PE players including the Blackstone Group, Goldman Sachs Capital Partners, Kohlberg Kravis Roberts and TPG acquired Biomet for $11.4 billion in 2007, placing medtech veteran Jeffrey Binder at the helm.